The Latest Breaking News from alopecia

Concert Pharmaceuticals Inc (NASDAQ:CNCE) has released highly positive Phase 3 data for their alopecia areata drug CTP-543 from the THRIVE-AA1 trial.  Mizuho says that the efficacy supports its view that CTP-543 potentially has best-in-class efficacy amongst the three main oral JAK inhibitors in late-stage development for alopecia areata (CTP-543, Eli Lilly And Co's (NYSE: LLY)…

Neighbours star Alan Fletcher took to social media to confirm to fans of the Australian soap that he has been diagnosed with hair loss disorder Alopecia Areata and decided to shave his head

Sam Taylor, 19, of Birmingham, says his eyebrow tattoos are now the envy of his female friends

Birmingham student Sam Taylor, 19, says his eyebrow tattoos are now the envy of his female friends

Sam, of Sutton Coldfield, Birmingham, saw all the hair on his head, face and body fall out and his confidence plummeted, as strangers asked if he had cancer, aged just 15

The US Patent Trial and Appeal Board (PTAB) issued a final written decision in favor of Concert Pharmaceuticals Inc (NASDAQ:CNCE) regarding the post-grant review (PGR) for the '659 method-of-use patent.  The '659 patent claims methods of treating hair loss, including alopecia areata with certain doses of CTP-543, a deuterated form of ruxolitinib, JAK 1/2…

Bonnie Pullan, 10, was reduced to tears by bullying schoolmates on a daily basis and later diagnosed with alopecia and told her hair is unlikely to grow back

Wendy Pullan first spotted a small bald patch on her daughter Bonnie's head while she was off school during a half-term holiday, with the rest of the youngster's hair soon falling out.

AnaptysBio Inc (NASDAQ:ANAB) announced topline data from a Phase 1 trial of ANB032, an anti-BTLA agonist antibody.  Topline data demonstrated favorable safety, tolerability, and rapid and sustained pharmacokinetics and pharmacodynamic profile, supporting the advancement of ANB032 into subsequent patient trials. ANB032 was generally well-tolerated, and no dose-limiting toxicities were observed. The Company said…